OKYO Pharma Limited (NASDAQ:OKYO – Get Rating)'s share price was down 2.9% during mid-day trading on Wednesday . The stock traded as low as $2.11 and last traded at $2.15. Approximately 1,731 shares were traded during trading, a decline of 95% from the average daily volume of 34,683 shares. The stock had previously closed at $2.22.
OKYO Pharma Stock Performance
The company's 50-day moving average is $2.14 and its 200-day moving average is $2.28.
About OKYO Pharma
(Get Rating)
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain.
See Also
- Get a free copy of the StockNews.com research report on OKYO Pharma (OKYO)
- Lucid Motors Faces a Reality That May Cloud a Bullish Perception
- Institutions Put Bottom In Rite Aid Shares
- Here's Why You Should Steer Clear of the FedEx Bounce
- Why Did Viking Therapeutics Stock Skyrocket
- NIKE, Inc Swooshes Higher On Results And Outlook
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.